Stress has been defined as the “The 21st Century Health Epidemic” by the World Health Organization; the panic for health as well as well as the fear of future uncertainty has turned around many aspects of everyday life. Moreover, the restrictive measures worsen people’s emotional states, leading to increased stress and anxiety worldwide. Consequently, the cognitive health market is rapidly expanding, and this enhanced interest may also be explained thanks to the several types of research done in the last years that connect the brain, the gut and the immune system.
ROELMI HPC has developed science-based probiotic concepts to align with the latest market requests and gave birth to SynBalance® Probiotics, the friendly bacteria selected for their intrinsic functional properties and improved in terms of stability to provide the best performance once formulated.
The two strains Lactobacillus reuteri PBS072 and Bifidumbacterium breve BB077 have been selected through in-vitro screening based on the improvement of serotonin and GABA synthesis and the enhancement of Lysine-Specific Demethylase1 (LSD1).